Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1999-08-25
2002-04-16
Sisson, Bradley L. (Department: 1655)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S024300, C536S025200, C536S025300
Reexamination Certificate
active
06372429
ABSTRACT:
The present invention relates to the field of genetic engineering. More particularly, the invention relates to a novel method for assembling two or more DNA fragments with high efficiency and yield.
BACKGROUND OF THE INVENTION
Building DNA constructs is the basis of genetic engineering. Manipulating recombinant DNA and its incorporation into vectors is common knowledge in the art. For example, fragments obtained by PCR techniques, may be incorporated into plasmids for cloning purposes. Generating specific DNA constructs by joining together different DNA segments, each encoding specific properties and/or possessing specific functions, is also known in the art. The state of the art has been published in a very large number of books, articles, patent applications, patents and the like, and is usually readily available and known to all of skill in the art. For example, a comprehensive account of DNA cloning procedures is provided in the three volume text by Sambrook et al. (1989) entitled “Molecular Cloning-a Laboratory Manual” 2nd edition, Cold Spring Harbor Laboratory Press. This extensive account of the prior art techniques for the combination of DNA fragments, cloning and expression thereof, is included herein by reference, in its entirety.
According to the present state of the art, the DNA fragments comprising the plasmid to be constructed are cleaved by restriction enzymes from larger entities. Next, they are connected utilizing the enzyme Ligase, which forms phosphodiester bonds between DNA fragments. Restriction enzymes cleave DNA leaving blunt or staggered ends (protruding short single stranded termini) also called overhangs. The efficiency of the ligation of blunt ended fragments is very low. Using staggered ended fragments elevates the efficiency of the ligation process, because the two fragments are being held together by the hydrogen-bonds between the complementary overhangs. Because the overhangs produced by most of the restriction enzymes are very short (2-4 bases), the connections between the complementary overhangs are weak and not very specific. Thus, when constructing a plasmid from restriction enzyme produced fragments, the yield is very low and there are many illegitimate ligations, leading to undesired products. It is therefore necessary to amplify the product usually by transfecting cells of choice such as bacterial cells, and then to identify and isolate colonies containing the DNA of choice from the ones containing undesired products. Only then can another DNA fragment be added by repetition of the whole procedure. As a result of this inefficient processes the building of complex DNA constructs is a laborious, time consuming and expensive process, in which each step necessitates the successful completion of the former. The construction of complex molecules may take several weeks to several months. Sometimes the completion of such constructs is not achieved at all. Another major drawback of the above mentioned method is that the availability of restriction site does not always coincide the construction demands. One way to overcome the above mentioned problems is to use short artificial DNA molecules called “linkers”. This however further complicates the construction process, reduces the yield, increases the percentage of wrong constructs and sometimes add undesired foreign sequences.
Several methods suggest the possibility of connecting DNA fragments by producing longer complementary overhangs (8-14 nucleotides). These connections are more stable than the ones produced by restriction enzymes. In fact, they are stable enough to render the ligation step unnecessary and the bacterial cells may be transformed right after the fragments are connected. The phosphodiester bonds are generated later, by the endogenous bacterial ligation machinery.
One prior method uses single strand extensions that are created by adding nucleotides at the 3′ end of a DNA strand in a template-independent fashion (Roychoudhury, R. Gene Amplif. Anal. 2:41-83, 1981). The enzyme used in this method, Terminal Transferase, incorporates nucleotides at the end of a double-stranded DNA fragment, thus creating a single-stranded tail. Since the enzyme uses the nucleotides randomly, the only way to ensure that the single-stranded tail will be complementary to a corresponding overhang created on a second DNA molecule, is to provide for each extension only one of the four nucleotides. The overhangs created with this method must therefore be homopolymeric, so that only four types of overhangs can be used, corresponding to the residues dA, dC, dG or dT. Since the overhangs created on both termini of a DNA fragment must be identical, cloning with this method is directionless and can only involve two fragments that are connected to each other at both ends, forming a circular molecule. Furthermore, the length of the overhangs cannot be specifically controlled. Finally, the method necessarily introduces an unwanted stretch of nucleotides into the final construct, the length of which cannot be determined exactly, making the method unsuitable for the purpose of cloning into expression vectors where the reading frame must be preserved.
According to another method (the commercial product “PCR-Direct™”, manufactured by CLONTECH, Inc., USA) the overhangs are generated utilizing the exonuclease activity of a DNA polymerase.
U.S. Pat. No. 5,137,814 describes another method in which the overhang is generated by providing at least one dU residue instead of dT, close to the terminus of the fragment. The position of the dU residues determines the length of the overhang. This method involves an a-purination of the Uracil bases. The a-purinated residues no longer have hydrogen-bond connections with their complementary bases on the opposite strand. Moreover, they destabilize the hydrogen bonds of their neighboring bases as well. The resulting 3′ protruding termini may connect to a complementary single strand sequence. A commercial product using this method is the CloneAmp® pAMP1 System (manufactured by Life Technologies Inc., USA). In the aforesaid method a 12-base overhang is used.
The use of overhangs longer than 4 nucleotides for the purpose of fragment cloning is also described in several other publications. Rashtchian et al. (Anal. Biochem. 206, p. 91-97, 1992), describe 12 nucleotide overhangs generated by Uracil DNA Glycosylase (UDG) to achieve high-efficiency cloning of single inserts into a vector. Kuijper et al. (Gene 112, p. 147-155, 1992) and Aslanidis et al. (PCR Methods Appl. 4:172-177, 1994), describe a cloning method wherein T4 polymerase is used together with a predetermined dNTP to generate overhangs of a certain length in PCR products. This method requires a specific sequence to be present in the PCR primer. Hsiao et al. (Nucleic Acids Res. 21, p. 5528-5529, 1993) and Yang et al. (Nucleic Acids Res. 21, 1889-1893, 1993) disclose generation of overhangs by the exonucleolytic activity of Exonuclease III (Exo III) or of T4 polymerase. Overhangs of 12 (Aslanidis), 8 (Yang) and 10-14 (Hsiao) nucleotides are disclosed.
The probability of producing a joint molecule composed from three molecules is the probability of joining of the first two molecules, multiplied by the probability of joining of the second and third molecules. If the joining of any two molecule is a rare event, due to the relatively short overhang, the joining of three or more molecules becomes practically useless for cloning purposes, because of the resulting low efficiency
It is therefore clear that the present state of the art is not satisfactory and there is a need for an improved method by which several DNA fragments can be effectively joined together in a directional, predetermined way, in one single-step. Such a method will remove the limitations imposed on genetic engineering by the aforementioned methods, and will thus revolutionize the way in which genetic engineering is performed.
SUMMARY OF THE INVENTION
In one aspect the invention is directed to a method for assembling two or more DNA fragments with high efficiency,
Gesher Israel Advanced Biotecs (1996) Ltd.
Lerner David Littenberg Krumholz & Mentlik LLP
Sisson Bradley L.
LandOfFree
Method for assembly of multiple DNA fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for assembly of multiple DNA fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for assembly of multiple DNA fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2894146